Competing on Quality
One of the principal goals of health policy makers, both public and private sector, has been to demonstrate that fostering competition among providers and insurers can bring down health care costs. The evidence, reflected in the declining rates of increase and, in some markets, actual decreases in premiums, suggests price competition works.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.